We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > BioXpress

News List

Abzena, BioXpress Therapeutics Enter Biosimilar Tie-up contractpharma
July 30, 2021
Abzena, a provider of solutions for biologics and bioconjugates, and BioXpress Therapeutics, a developer of monoclonal antibody (mAb) biosimilar therapeutics, have partnered to support biosimilar development for third party customers.
Abzena and BioXpress Therapeutics announce partnership to support the development and manufacture of biosimilars for global customers. firstwordpharma
July 28, 2021
Abzena, a Global Partner Research Organization for integrated bench to patient solutions for biologics and bioconjugates, and BioXpress Therapeutics, a world-class leading developer of high quality, monoclonal antibody (mAb) biosimilar therapeutics